- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03735342
HEARt Sounds: Audio Recordings to Improve Discharge Communication for Cardiology Inpatients
HEARt Sounds: A Pilot Randomized Trial to Determine the Feasibility and Acceptability of Audio Recordings to Improve Discharge Communication for Cardiology Inpatients
Study Overview
Detailed Description
The study objective is to assess the feasibility and acceptability of providing audio recorded discharge instructions to patients discharged from an inpatient cardiology service using a two-arm randomized controlled design. Specifically, this pilot study aims to: 1) Determine whether providing audio recorded discharge instructions as a supplemental discharge communication tool is feasible for cardiology providers and patients to use during the inpatient discharge discussion, 2) Determine whether it is acceptable for patients and families to use audio recorded discharge instructions after hospital discharge to self-manage care, and 3) Explore the impact of audio recording on patients' understanding of discharge instructions, ability to self-manage care and ability to adhere to prescribed medications.
On the day of discharge, enrolled patients will be randomized to a usual care arm, which includes bedside discussion and review of written discharge instructions with the discharging provider, or to an intervention arm, which includes bedside discussion and review of written discharge instructions with the discharging provider and an audio recording of that bedside discharge discussion using block randomization at the provider level. All participants randomized to the intervention arm will receive a portable, electronic recording device with audio playback that contains a recording of the bedside discharge discussion, and will also have the option to record the discharge discussion on a smartphone or receive access to the recording online, via the Open Recording Automated Logging System (ORALS). The hypothesis is providing audio recordings of discharge instructions will be feasible and acceptable to cardiology patients and providers.
One week after discharge, all enrolled patients (both arms) will be contacted via telephone to complete an interview about the use of written discharge instructions and a survey about understanding of discharge instructions, confidence and ability to self-manage care, and medication adherence. In addition, patients in the intervention arm will be interviewed about how the audio recording of the discharge discussion was used.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth Hitchcock Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years of age or older
- Cardiology inpatients
- Comfortable reading and writing in English
- Willing to have discharge conversation recorded
Exclusion Criteria:
- Patients who are unable or unwilling to provide written informed consent
- Diagnosis of dementia, schizophrenia and other psychotic disorders
- Have a substance-abuse disorder
- Severe uncorrected vision or hearing problems
- Currently living in skilled nursing facility or hospice
- Planned discharge to a structured facility (e.g., skilled nursing facility, intermediate care facility, hospice)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Audio Recording
Participants receive a verbal discharge discussion with a provider, written discharge instructions and a re-playable audio recording of the discharge discussion with the discharging provider.
|
All participants will be provided with a re-playable audio recording of the discharge discussion on a portable electronic device.
In addition, participants will have the option to record the discharge discussion on a personally-owned smartphone or receive access to the recording online, via the Open Recording Automated Logging System (ORALS).
|
|
No Intervention: Usual care
Participants receive a verbal discharge discussion with a provider and written discharge instructions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient enrollment (Feasibility)
Time Frame: Time 1-Day of discharge, immediately post randomization
|
The proportion of eligible cardiology inpatients who agreed to take part in the research.
|
Time 1-Day of discharge, immediately post randomization
|
|
Intervention fidelity (Feasibility)
Time Frame: Time 1-Day of discharge, immediately post randomization
|
The proportion of cardiology inpatients in the intervention arm that received the audio recording intervention with full adherence to a pre-defined protocol fidelity checklist.
Any deviations will be documented.
|
Time 1-Day of discharge, immediately post randomization
|
|
Patient use of intervention (Acceptability)
Time Frame: Time 2-One week after discharge, post randomization
|
The proportion of discharged cardiology patients in the intervention arm who used the audio recording between the day of discharge and a one-week follow up telephone call initiated by the research team.
|
Time 2-One week after discharge, post randomization
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in patient activation
Time Frame: Time 0-Day of discharge, before randomization, Time 1-Day of discharge, immediately post randomization, Time 2-One week after discharge, post randomization
|
Measured using the Patient Activation Measure-13 (PAM-13).
The PAM-13 is a 13-item survey that assesses a person's underlying knowledge, skills and confidence integral to managing his or her own health and healthcare.
Each item is measured on a 4-point rating scale ranging from 1 (strongly disagree) to 4 (strongly agree).
Scores for individual items are added to yield a sum score ranging from 0 to 100, with higher scores indicating greater self-management ability.
|
Time 0-Day of discharge, before randomization, Time 1-Day of discharge, immediately post randomization, Time 2-One week after discharge, post randomization
|
|
Change in patient health confidence
Time Frame: Time 0-Day of discharge, before randomization, Time 1-Day of discharge, immediately post randomization, immediately post randomization, Time 2-One week after discharge, post randomization
|
The proportion of patients in the intervention arm, compared to patients in the usual care arm, who report high confidence measured using an adapted version of the Health Confidence Measure that includes three response options; "very confident", "somewhat confident" and "not confident".
Response options are categorized, with "very confident" indicating high health confidence vs. "somewhat confident" and "not confident" indicating low health confidence.
|
Time 0-Day of discharge, before randomization, Time 1-Day of discharge, immediately post randomization, immediately post randomization, Time 2-One week after discharge, post randomization
|
|
Change in patient ability to understand health information
Time Frame: Time 0-Day of discharge, before randomization, Time 1-Day of discharge, immediately post randomization, immediately post randomization, Time 2-One week after discharge, post randomization
|
The proportion of patients in the intervention arm, compared to patients in the usual care arm, who report a high ability to understand health information measured using an adapted version of the Health Confidence Measure that includes three response options; "very understandable", "somewhat understandable" and "not understandable".
Response options are categorized, with "very understandable" indicating a high ability to understand health information vs. "somewhat understandable" and "not understandable" indicating a low ability to understand health information.
|
Time 0-Day of discharge, before randomization, Time 1-Day of discharge, immediately post randomization, immediately post randomization, Time 2-One week after discharge, post randomization
|
|
Change in patient general medical adherence
Time Frame: Time 0-Day of discharge, before randomization, Time 2-One week after discharge, post randomization
|
Measured using the Medical Outcomes Study Measure of Adherence (MOS).
The 5-item MOS measures general adherence to medical advice on a 6-point rating scale ranging from 1 (none of the time) to 6 (all of the time).
Scores for individual items are averaged to yield a summary score ranging from 1 to 6, with higher scores indicating better adherence.
|
Time 0-Day of discharge, before randomization, Time 2-One week after discharge, post randomization
|
|
Patient assessment of discharging provider communication ability
Time Frame: Time 1-Day of discharge, immediately post randomization
|
Measured using the Communication Assessment Tool (CAT).
The 15-item CAT measures patient perceptions of physician performance in the area of interpersonal and communication skills using a 5-point rating scale ranging from 1 (poor) to 5 (excellent).
The percentage of items scored as excellent is calculated as the percentage of items with a score of 5 (excellent) out of the number of items answered.
|
Time 1-Day of discharge, immediately post randomization
|
|
Patient adherence to medications
Time Frame: Time 2-One week after discharge, post randomization
|
Measured using the Adherence to Refills and Medications Scale (ARMS-7).
The 7-item ARMS-7 measures medication adherence and refill behaviors on a 4-point rating scale ranging from 1 (none of the time) to 4 (all of the time).
Individual items are added and can be treated as a continuous measure or dichotomized as 7 or >7, with lower scores indicating better adherence.
|
Time 2-One week after discharge, post randomization
|
|
Rate of patient-generated post-discharge phone calls
Time Frame: Time 2-One week after discharge, post randomization
|
The number of patient-generated post-discharge phone calls to the outpatient cardiology clinic or hospital emergency telephone line between the time of discharge and the research team's post-discharge follow-up telephone interview (both arms), according to data provided by the hospital's informatics team and the electronic medical record.
|
Time 2-One week after discharge, post randomization
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Paul J Barr, PhD, MSc, Dartmouth College
- Principal Investigator: Stacey L Schott, MD, Dartmouth-Hitchcock Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D18184
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCardiovascular Disease (CVD) | Gender Incongruence | Cardiovascular (CV) Risk | Cardiovascular Health Status | Cardiovascular Disease Prevention | Cardiovascular Disease Acute | Cardiovascular Disease Risk FactorItaly
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University College DublinBeacon Hospital, IrelandRecruitingCoronary Artery Disease (CAD) | Cardiovascular Diseases (CVD) | Cardiovascular Disease Prevention | Cardiovascular Disease Risk FactorIreland
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Istituti Clinici Scientifici Maugeri SpAA.R.C.A Associazioni Regionali Cardiologi AmbulatorialiRecruiting
-
AmgenRecruitingCardiovascular DiseaseItaly, Germany, United States, China, Japan, Spain, Denmark, Australia, France, Canada, Netherlands
-
University of ReadingBiotechnology and Biological Sciences Research Council; Royal Berkshire NHS...Not yet recruiting
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
Clinical Trials on Audio Recording
-
Dartmouth-Hitchcock Medical CenterNational Institutes of Health (NIH); National Institute on Aging (NIA); Vanderbilt... and other collaboratorsCompletedHypertension | Diabetes MellitusUnited States
-
Mayo ClinicCompleted
-
East Tennessee State UniversityWithdrawnDementia | Alzheimer DiseaseUnited States
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingProstate CancerRussian Federation
-
University of California, San FranciscoConquer Cancer FoundationCompletedProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Duke UniversityNational Cancer Institute (NCI)TerminatedNewly Diagnosed Cancer Patients Who Are HIV Positive and Their Treating OncologistUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHealthy VolunteersUnited States
-
Canterbury Christ Church UniversityCompleted
-
University Health Network, TorontoUniversity of Toronto; The Salvation Army Toronto Grace Health CentreRecruiting
-
Oman Ministry of HealthRecruitingMeningitis in ChildrenOman